Drug Profile
MEDI 578
Alternative Names: Anti-NGF monoclonal antibody (MEDI-578); MEDI-578Latest Information Update: 09 Aug 2021
Price :
$50
*
At a glance
- Originator MedImmune
- Class Antirheumatics; Immunoglobulins; Monoclonal antibodies
- Mechanism of Action Nerve growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Musculoskeletal pain
Most Recent Events
- 30 Jun 2012 Discontinued - Phase-I for Musculoskeletal pain in United Kingdom (IV)
- 13 Jul 2010 Suspended - Phase-I for Musculoskeletal pain (in osteoarthritis patients) in United Kingdom (IV)
- 28 Feb 2010 Phase-I clinical trials in Musculoskeletal pain (in osteoarthritis patients) in United Kingdom (IV)